CSIMarket Company Name, Ticker, Industry, else..
 
Envveno Medical Corporation  (NASDAQ: NVNO)
 

Envveno Medical's Customers Performance

NVNO


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
NVNO's Source of Revenues

• List of NVNO Customers




for the same period Envveno Medical Corporation

• List of NVNO Customers





Envveno Medical's Comment on Sales, Marketing and Customers



In the United States, clinical trials supporting a Premarket Approval (PMA) submission for medical devices classified as Class III, which pose significant risk to human health, require an Investigational Device Exemption (IDE) application approved by the U.S. Food and Drug Administration (FDA) prior to initiating human testing. The enVVe System specifically requires IDE approval before commencing clinical trials in the U.S. Each clinical trial must also receive approval and oversight from an Institutional Review Board (IRB) at every participating clinical site. The FDA and IRB approvals determine the number of investigational sites and patient enrollment for the trials. Throughout the study, sponsors and clinical investigators are required to comply with FDA regulations, including monitoring, reporting, and ensuring informed consent from patients.





Envveno Medical’s Comment on Sales, Marketing and Customers


In the United States, clinical trials supporting a Premarket Approval (PMA) submission for medical devices classified as Class III, which pose significant risk to human health, require an Investigational Device Exemption (IDE) application approved by the U.S. Food and Drug Administration (FDA) prior to initiating human testing. The enVVe System specifically requires IDE approval before commencing clinical trials in the U.S. Each clinical trial must also receive approval and oversight from an Institutional Review Board (IRB) at every participating clinical site. The FDA and IRB approvals determine the number of investigational sites and patient enrollment for the trials. Throughout the study, sponsors and clinical investigators are required to comply with FDA regulations, including monitoring, reporting, and ensuring informed consent from patients.







NVNO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Envveno Medical Corporation 6.07 0.00 -18.82 33
SUBTOTAL 0.00 0.00 0.00 -

Sources: Envveno Medical Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Envveno Medical Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Envveno Medical Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.